Moderna President Stephen Hoge Exercises Options and Sells $11.7M in Stock Under 10b5-1 Plan

Insider Transaction Summary

• Reporting Owner: Stephen Hoge, President of Moderna, Inc. ($MRNA)
• Transaction Dates: September 14, 2026 – September 15, 2026
• Filing Date: September 16, 2026
• Nature of Transactions: Option exercise and partial share sale pursuant to a Rule 10b5-1 trading plan adopted on June 15, 2026.

Key Breakdown:

1. Option Exercises:

   • 2026-09-14: Exercised stock options for 76,453 shares of Common Stock at $12.21 per share.
   • 2026-09-15: Exercised stock options for 76,452 shares of Common Stock at $12.21 per share.
   • Total Exercised: 152,905 shares.

2. Open Market Sales:

   • 2026-09-14: Sold 40,294 shares at a weighted average price of $144.13 (approx. $5.81M).
   • 2026-09-15: Sold 40,281 shares at a weighted average price of $146.07 (approx. $5.88M).
   • Total Sold: 80,575 shares for gross proceeds of approximately $11,691,419.89.

Post-Transaction Holdings:

• Direct Ownership: 1,562,029 shares (net increase of 72,330 direct shares following the exercises and sales).
• Indirect Ownership: 4,116 shares held by Valhalla, LLC and 151,933 shares held by Trust.
• Remaining Derivative Holdings: 305,810 vested stock options expiring February 23, 2027.